glp 1 agonist saxenda Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First GLP-1 Generic
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First GLP-1 Generic](https://www.americanmedspa.org/wp-content/uploads/2026/03/semaglutide-hero.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First GLP-1 Generic](https://biopharmaboardroom.com/uploads/articles/first_generic_glp_1_for_obesity_gains_fda_approval_404308_960x540-4429.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First GLP-1 Generic](https://secure.proactrx.com/media/filer_public/f6/6f/f66fd578-4e9f-4c30-a83d-88de87432593/saxenda_approval.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First GLP-1 Generic](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2024/05/2394973-What-to-know-about-GLP-1-medications-for-weight-loss-Ozempic-Saxenda-and-more-Header-92a9c6-1024x575.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First GLP-1 Generic](https://v.cdn.ww.com/media/system/cms/us/SAXENDA_BATHROOM_SHOT_V01_new.jpg)























